Search
Search titles only
By:
Search titles only
By:
Log in
Register
Search
Search titles only
By:
Search titles only
By:
Menu
Install the app
Install
Forums
New posts
All threads
Latest threads
New posts
Trending threads
Trending
Search forums
What's new
New posts
New ads
New profile posts
Latest activity
Free Ads
Latest reviews
Search ads
Members
Current visitors
New profile posts
Search profile posts
Contact us
Latest ads
Ad icon
🎮 INDIAN PSN GIFT CARDS AVAILABLE NOW! 🎮
madukaperera
Updated:
Yesterday at 12:57 PM
🚀 Google AI PRO – 18 Months | Rs. 850 Only
lkkolla
Updated:
Monday at 4:56 PM
🔒 NordVPN Premium – 3 Months
hrdilshan
Updated:
Thursday at 8:29 PM
🚀 Microsoft Office 365 Pro Plus – Lifetime Access! 🚀
hrdilshan
Updated:
Thursday at 8:28 PM
Linkedin Premium Business / Careere /Sales Navigator - 1/2/3/6/9/12 Months - Reddem Link
hrdilshan
Updated:
Thursday at 8:27 PM
Electronics
Vehicles
Property
Search
Reply to thread
Forums
ElaKiri.com
News and Updates
New Study - Vitamin D Supplementation can reduce Dementia by 40%
Get the App
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Message
<blockquote data-quote="imhotep" data-source="post: 28688202" data-attributes="member: 562115"><p>A new Canadian study adjusted for age, sex, education, race, cognitive diagnosis, depression, and <strong>apolipoprotein E (<em>APOE</em>) ε4</strong> has been released. It was known that lower vitamin D status may be associated with increased risk of developing Alzhimer's and dementia. </p><p></p><p>Although about 70 genetic regions are associated with Alzheimer's, one quite well known gene is the A<strong>polipoprotein E (<em>APOE</em>)</strong> gene. The <em>APOE</em> gene is involved in making a protein that helps carry cholesterol and other types of fat in the bloodstream. Problems in this process are thought to contribute to the development of Alzheimer’s. <em>APOE</em> comes in several forms, called alleles (e.g., <em>ε2, ε3</em>).</p><p></p><p><em>APOE ε2</em> may provide some protection against the disease. If Alzheimer’s occurs in a person with this allele, it usually develops later in life than it would in someone with the APOE ε4 gene. Roughly 5% to 10% of people have this allele.</p><p><em>APOE ε3</em>, the most common allele, is believed to have a neutral effect on the disease — neither decreasing nor increasing risk of Alzheimer’s.</p><p><em>APOE ε4</em> increases risk for Alzheimer’s and is associated with an earlier age of disease onset in certain populations. About 15% to 25% of people have this allele, and 2% to 5% carry two copies.</p><p>Each person inherits two <em>APOE</em> alleles, one from each biological parent, meaning people can have one of six possible combinations: 2/2, 2/3, 2/4, 3/3, 3/4, and 4/4. Having two copies of <em>APOE ε4</em> is associated with a higher risk of Alzheimer’s than having one copy. While inheriting <em>APOE ε4</em> increases a person’s risk of Alzheimer’s, some people with an <em>APOE ε4</em> allele never develop the disease.</p><p></p><p><strong>Study Highlights.</strong></p><ul> <li data-xf-list-type="ul"><strong>In a prospective cohort study, we assessed effects of Vitamin D on dementia incidence in 12,388 participants from the National Alzheimer's Coordinating Center dataset.</strong></li> <li data-xf-list-type="ul"><strong>Vitamin D exposure was associated with 40% lower dementia incidence versus no exposure.</strong></li> <li data-xf-list-type="ul"><strong>Vitamin D effects were significantly greater in females versus males and in normal cognition versus mild cognitive impairment.</strong></li> <li data-xf-list-type="ul"><strong>Vitamin D effects were significantly greater in apolipoprotein E ε4 non-carriers versus carriers.</strong></li> <li data-xf-list-type="ul"><strong>Vitamin D has potential for dementia prevention, especially in the high-risk strata.</strong></li> </ul></blockquote><p></p>
[QUOTE="imhotep, post: 28688202, member: 562115"] A new Canadian study adjusted for age, sex, education, race, cognitive diagnosis, depression, and [B]apolipoprotein E ([I]APOE[/I]) ε4[/B] has been released. It was known that lower vitamin D status may be associated with increased risk of developing Alzhimer's and dementia. Although about 70 genetic regions are associated with Alzheimer's, one quite well known gene is the A[B]polipoprotein E ([I]APOE[/I])[/B] gene. The [I]APOE[/I] gene is involved in making a protein that helps carry cholesterol and other types of fat in the bloodstream. Problems in this process are thought to contribute to the development of Alzheimer’s. [I]APOE[/I] comes in several forms, called alleles (e.g., [I]ε2, ε3[/I]). [I]APOE ε2[/I] may provide some protection against the disease. If Alzheimer’s occurs in a person with this allele, it usually develops later in life than it would in someone with the APOE ε4 gene. Roughly 5% to 10% of people have this allele. [I]APOE ε3[/I], the most common allele, is believed to have a neutral effect on the disease — neither decreasing nor increasing risk of Alzheimer’s. [I]APOE ε4[/I] increases risk for Alzheimer’s and is associated with an earlier age of disease onset in certain populations. About 15% to 25% of people have this allele, and 2% to 5% carry two copies. Each person inherits two [I]APOE[/I] alleles, one from each biological parent, meaning people can have one of six possible combinations: 2/2, 2/3, 2/4, 3/3, 3/4, and 4/4.[B] [/B]Having two copies of [I]APOE ε4[/I] is associated with a higher risk of Alzheimer’s than having one copy. While inheriting [I]APOE ε4[/I] increases a person’s risk of Alzheimer’s, some people with an [I]APOE ε4[/I] allele never develop the disease. [B]Study Highlights.[/B] [LIST] [*][B]In a prospective cohort study, we assessed effects of Vitamin D on dementia incidence in 12,388 participants from the National Alzheimer's Coordinating Center dataset.[/B] [*][B]Vitamin D exposure was associated with 40% lower dementia incidence versus no exposure.[/B] [*][B]Vitamin D effects were significantly greater in females versus males and in normal cognition versus mild cognitive impairment.[/B] [*][B]Vitamin D effects were significantly greater in apolipoprotein E ε4 non-carriers versus carriers.[/B] [*][B]Vitamin D has potential for dementia prevention, especially in the high-risk strata.[/B] [/LIST] [/QUOTE]
Insert quotes…
Verification
Winadiyakata thappara keeyak tibeda?
Post reply
Top
Bottom